Tokyo, May 30 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061743) titled 'A real-world study on gradually increasing the dose (incremental reintroduction and desensitization) after side effects from anti-tuberculosis drugs' on May 29.

Study Type: Observational

Primary Sponsor: Institute - NHO Tokyo National Hospital

Condition: Condition - Tuberculosis Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To clarify the real-world practice of planned low-dose incremental reintroduction (low-dose incremental reintroduction and desensitization therapy) after the onset of adverse reactions to anti-tuberculosis drugs, using electronic medical recor...